How to take dotalizumab (Jemperli)

The use of dotalizumab (Jemperli) must strictly follow the doctor's prescription and medical guidance, because the treatment plan will vary according to the patient's specific situation. The following is a general overview of dosalumab administration:

1.Route of administration: Dotilizumab is usually administered by intravenous injection. This means that the medication is injected into the patient's vein through an IV.

2.Treatment frequency: The specific frequency and duration of treatment will be based on the patient's condition and the doctor's recommendations. Typically, treatment with dolutelimumab is given on a regular basis and may involve multiple courses.

3.Dosage: The dosage of dolutelimumab is based on the patient's weight, severity of illness, and other individual characteristics. Your doctor will use these factors to determine the exact dosage for each treatment.

4.Treatment monitoring: During treatment with dotalizumab, patients need to be monitored by their doctor regularly. This includes examination of the occurrence of immune-related side effects and assessment of drug efficacy.

5.Drug Interactions: Patients should inform their doctors about other medications they are taking, as dotalizumab may interact with other medications. Doctors will consider these factors to optimize treatment options.

6.Medication in special populations: For special populations, such as elderly patients, children, or patients with specific diseases, the medication method may require special considerations. Doctors will adjust treatment plans based on these special circumstances.

Dotalizumab is not currently on the market in China, and it is not included in medical insurance. Patients cannot purchase it domestically and need to purchase dotalizumab through overseas channels. There are only original drugs available abroad, mainly from the United States, and the price is as high as about 50,000 yuan.